Margherita-PROSAFE:Promoting Patient Safety and Quality Improvement in Critical Care
1 other identifier
observational
250,000
1 country
1
Brief Summary
The general objective is to promote patient safety and quality improvement in critical care towards a significant reduction of observed mortality rates and economic costs through the improvement of outcomes and reduction of medical errors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 22, 2017
CompletedFirst Posted
Study publicly available on registry
October 11, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMarch 16, 2022
March 1, 2022
1.1 years
December 22, 2017
March 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Hospital mortality
Hospital mortality is required to calculated different indicators: * SMR: it is the ratio between the mortality rate actually observed in a specific centre and the mortality that would have been expected had this centre performed according to the average of all the other participating centers, as they behaved in the same period, in the same country. * VLAD: it shows the performance of each individual ICU (expressed along the y axis) against time (reported on the x axis). When the plot rises, it means that in the period in question the ICU performed better than the average, in terms of lives saved, and vice versa when the plot declines, in terms of lives lost compared to the average performance. * GiViTI Calibration belt: it represents the confidence band that correlates the observed and the expected (according to the average performance) mortality.
1 year
Eligibility Criteria
Patients admitted in partecipating ICU
You may qualify if:
- All the patients admitted in ICU
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensivalead
- European Commissioncollaborator
- Friedrich Schiller University of Jenacollaborator
- General Hospital of Novo mestocollaborator
- Intensive Care Forum (ICF)collaborator
- Medical University of Warsawcollaborator
- University of Nicosiacollaborator
- Semmelweis University Budapestcollaborator
- University College, Londoncollaborator
- Univerzitetni Klinikni Center Ljubljanacollaborator
- Ben-Gurion University of the Negevcollaborator
- University of Crete Medical School - University Hospital of Heraklioncollaborator
- Orobix Srlcollaborator
Study Sites (1)
Ospedale A. Manzoni, U.O. Anestesia e Rianimazione 1
Lecco, Lombardy, 23900, Italy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2017
First Posted
October 11, 2018
Study Start
November 1, 2008
Primary Completion
December 1, 2009
Study Completion
December 1, 2025
Last Updated
March 16, 2022
Record last verified: 2022-03